Skip to content

Clinical trials

Active, not recruiting Neurofibroma, Plexiform trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurofibroma, Plexiform Status: Active, not recruiting Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20161
20181
20192
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
AstraZeneca1
Children's National Research Institute1
Memorial Sloan Kettering Cancer Center1
Novartis Pharmaceuticals1
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.1
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurofibroma, Plexiform9
Neurofibromatosis 18
Neurofibroma3
Neuroblastoma2
Astrocytoma1
Brain Neoplasms1
Central Nervous System Neoplasms1
Ganglioglioma1
Ganglioneuroma1
Glioblastoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.